569 — Vicplas International Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Vicplas International, fiscal year end - July 31st, SGD millions except per share, conversion factor applied.

	2022 July 31st	2023 July 31st	2024 July 31st	2025 July 31st	2026 July 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Preliminary
Revenue
Total Revenue	131	129	102	116	127
Cost of Revenue
Gross Profit	68.8	66.8	52.9	61.5	67.5
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	119	122	102	116	130
Operating Profit	11.9	6.77	-0.07	0.093	-2.44
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	11	5.61	-1.13	-1.65	-4.48
Provision for Income Taxes
Net Income After Taxes	8.84	4.24	-1.36	-2.36	-5.14
Net Income Before Extraordinary Items
Net Income	8.84	4.24	-1.36	-2.36	-5.14
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	8.84	4.24	-1.36	-2.36	-5.14
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.017	0.008	-0.002	-0.004	-0.009
Dividends per Share